Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             36 results found
no title author magazine year volume issue page(s) type
1 Commentary on cardiovascular risk Gaston, Robert
2003
17 4S2 p. S46-
1 p.
article
2 Commentary on conversion strategies Gaston, Robert
2003
17 4S2 p. S59-
1 p.
article
3 Commentary on novel immunosuppressive strategies: steroid avoidance Gaston, Robert
2003
17 4S2 p. S61-
1 p.
article
4 Commentary on optimal maintenance immunosuppression: interpreting registry data Gaston, Robert
2003
17 4S2 p. S54-
1 p.
article
5 Commentary on pretransplantation: identifying risk factors Gaston, Robert
2003
17 4S2 p. S36-
1 p.
article
6 Commentary on pretransplantation: removing immunologic barriers Gaston, Robert
2003
17 4S2 p. S32-
1 p.
article
7 Commentary on reducing complications after transplantation: posttransplant diabetes mellitus Gaston, Robert
2003
17 4S2 p. S42-
1 p.
article
8 Commentary on reducing complications after transplantation: the significance of renal allograft function Gaston, Robert
2003
17 4S2 p. S40-
1 p.
article
9 Commentary on reducing infectious risks: polyoma (BK) virus Gason, Robert
2003
17 4S2 p. S49-
1 p.
article
10 Commentary on tacrolimus-sirolimus Gaston, Robert
2003
17 4S2 p. S65-
1 p.
article
11 Conclusion Gaston, Robert
2003
17 4S2 p. S70-
1 p.
article
12 Contents 2003
17 4S2 p. ii-
1 p.
article
13 Introduction Gaston, Robert
2003
17 4S2 p. S31-
1 p.
article
14 Masthead 2003
17 4S2 p. i-
1 p.
article
15 Study 1: a fresh look at early serum creatinine at one, two, and three years as a surrogate marker for long-term outcomes in renal immunosuppression McEwan, Phil C.
2003
17 4S2 p. S41-
1 p.
article
16 Study 1: an open-label pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in renal allograft recipients on a regimen of maintenance therapy with moderate renal insufficiency Peddi, V.Ram
2003
17 4S2 p. S60-
1 p.
article
17 Study 1: a prospective, randomized, double-blind, multicenter trial of early (7-day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction Woodle, E.S.
2003
17 4S2 p. S62-S63
2 p.
article
18 Study 1: a prospective, randomized study of cyclosporine-mycophenolate mofetil versus tacrolimus-sirolimus with rapid discontinuation of prednisone Kandaswamy, Raja
2003
17 4S2 p. S43-S44
2 p.
article
19 Study 2: a randomized, single-center, long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (neoral) and sirolimus after renal transplantation: 1-year interim analysis Ciancio, Gaetano
2003
17 4S2 p. S68-S69
2 p.
article
20 Study 2: BK polyomavirus nephritis and acute rejection tend to affect distinct groups of renal allograft recipients: a role for gender, race, and tacrolimus levels Rocha, Paulo N.
2003
17 4S2 p. S51-
1 p.
article
21 Study 1: characterization of acute rejection episodes after pre-emptive plasmapheresis and cytomegalovirus hyperimmune globulin to abrogate a positive crossmatch and allow live donor renal transplantation Sonnenday, Christopher J.
2003
17 4S2 p. S33-
1 p.
article
22 Study 2: comparison of tacrolimus and sirolimus combination with tacrolimus and mycophenolate mofetil in kidney transplant recipients with steroid avoidance Kumar, Aparna
2003
17 4S2 p. S45-
1 p.
article
23 Study 3: early steroid cessation-avoidance regimens are associated with a lower incidence of polyomavirus nephropathy compared with steroid-based immunosuppression in kidney transplant recipients Trofe, J.
2003
17 4S2 p. S52-S53
2 p.
article
24 Study 1: effect of type of immunosuppression reduction in patients with BK allograft nephropathy Ramos, Emilio
2003
17 4S2 p. S50-
1 p.
article
25 Study 2: evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the National Institutes of Health IG02 trial Jordan, Stanley C.
2003
17 4S2 p. S34-
1 p.
article
26 Study 1: graft survival after living donor renal transplantation: a comparison between tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids Bunnapradist, Suphamai
2003
17 4S2 p. S55-S56
2 p.
article
27 Study 1: long-term cardiovascular risk after kidney transplantation First, M.R.
2003
17 4S2 p. S47-
1 p.
article
28 Study 1: one-year results of the first prospective, randomized, multicenter kidney transplant study comparing tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil combination therapy Mendez, R.
2003
17 4S2 p. S66-S67
2 p.
article
29 Study 3: outcome of ABO-incompatible kidney transplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroids Tanabe, Kazunari
2003
17 4S2 p. S35-
1 p.
article
30 Study 3: posttransplant diabetes mellitus: evidence for glucose intolerance and insulin resistance existing before transplantation Pesavento, Todd E.
2003
17 4S2 p. S39-
1 p.
article
31 Study 2: relationship between pretransplant obesity and posttransplant cardiovascular events, diabetes mellitus, and graft and patient survival in renal transplant recipients de Mattos, Angelo M.
2003
17 4S2 p. S38-
1 p.
article
32 Study 2: short-term benefit of tacrolimus versus cyclosporine therapy after renal transplantation: an analysis of United Network for Organ Sharing/Organ Procurement and Transplantation Network database Bresnahan, Barbara A.
2003
17 4S2 p. S57-
1 p.
article
33 Study 2: steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus: analysis of renal function beyond 1 year Hricik, Donald E.
2003
17 4S2 p. S64-
1 p.
article
34 Study 2: tacrolimus as secondary intervention versus continuation of cyclosporine in patients at risk for chronic renal allograft failure results in improved renal function, decreased cardiovascular risk, and no increased risk for diabetes Waid, Thomas H.
2003
17 4S2 p. S48-
1 p.
article
35 Study 3: the effect of maintenance immunosuppression medication on the change in kidney allograft function Gill, John S.
2003
17 4S2 p. S58-
1 p.
article
36 Study 1: unexpected high incidence of coronary artery disease and abnormal platelet reactivity in long-term pediatric kidney transplant recipients Kim, Dean Y.
2003
17 4S2 p. S37-
1 p.
article
                             36 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands